Hawkins (HWKN) Projected to Post Quarterly Earnings on Wednesday

Key Points

• Hawkins (NASDAQ:HWKN) is expected to report Q4 2026 results after the market closes on Wednesday, May 13, with analysts projecting EPS $0.77 and revenue of $255.284 million; the earnings call is scheduled for 4:10 PM ET.
• The stock carries a market cap of $3.49 billion and a relatively high valuation (PE 42.28), trading within a one-year range of $115.35–$186.15 and with 50/200-day SMAs of $151.20/$146.01.
• Analysts have a consensus rating of Hold with an average target price of $200, and institutional investors own roughly 69.7% of the shares amid recent hedge fund activity.

Hawkins (NASDAQ:HWKN - Get Free Report) is anticipated to issue its Q4 2026 results after the market closes on Wednesday, May 13th. Analysts expect the company to announce earnings of $0.77 per share and revenue of $255.2840 million for the quarter. Interested persons are encouraged to explore the company's upcoming Q4 2026 earning overview page for the latest details on the call scheduled for Wednesday, May 13, 2026 at 4:10 PM ET.

Hawkins Stock Performance

NASDAQ:HWKN opened at $167.00 on Wednesday. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.35 and a quick ratio of 1.46. The firm has a market cap of $3.49 billion, a PE ratio of 42.28, a P/E/G ratio of 3.16 and a beta of 0.81. The firm has a 50 day simple moving average of $151.20 and a 200-day simple moving average of $146.01. Hawkins has a 1-year low of $115.35 and a 1-year high of $186.15.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on the stock. BWS Financial reiterated a "buy" rating and set a $200.00 price objective on shares of Hawkins in a report on Monday, March 23rd. Weiss Ratings restated a "hold (c+)" rating on shares of Hawkins in a research note on Friday, April 10th. One equities research analyst has rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, Hawkins presently has a consensus rating of "Hold" and an average target price of $200.00.

Hedge Funds Weigh In On Hawkins

A number of institutional investors and hedge funds have recently added to or reduced their stakes in HWKN. Amundi boosted its holdings in shares of Hawkins by 10.5% in the third quarter. Amundi now owns 5,769 shares of the specialty chemicals company's stock valued at $1,059,000 after acquiring an additional 546 shares in the last quarter. Diversify Wealth Management LLC acquired a new position in shares of Hawkins in the 2nd quarter worth $939,000. Tidal Investments LLC raised its holdings in Hawkins by 38.9% during the 2nd quarter. Tidal Investments LLC now owns 5,208 shares of the specialty chemicals company's stock worth $740,000 after buying an additional 1,459 shares during the period. Occudo Quantitative Strategies LP acquired a new stake in shares of Hawkins during the third quarter valued at approximately $459,000. Finally, Vestcor Inc acquired a new stake in Hawkins during the 3rd quarter valued at $391,000. 69.71% of the stock is owned by institutional investors.

Hawkins Company Profile

Hawkins, Inc NASDAQ: HWKN is a specialty chemical company that produces and distributes water-treatment and industrial chemicals across North America. Founded in 1938 and headquartered in Roseville, Minnesota, the company has built a network of manufacturing facilities and distribution centers that serve municipal, industrial and commercial customers. As a publicly traded entity, Hawkins leverages its long-standing presence in the chemical distribution industry to provide tailored solutions for complex water-treatment challenges and specialty chemical needs.

Hawkins' product portfolio encompasses a wide range of chemicals, including sodium hypochlorite, sodium hydroxide, hydrogen peroxide, chlorine, acids and specialty blends.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.